AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Viglimepol Tablet

Prescription Icon
Prescription Required

Marketer

Medipol Pharmaceuticals India Pvt Ltd

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Viglimepol Tablet

Diabetol Duo tablets combine two medications to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps prevent severe diabetic complications like renal impairment and vision loss, and may lower the risk of cardiovascular events. Diabetol Duo may be prescribed independently or in conjunction with other antidiabetic therapies. Optimal efficacy requires adherence to a balanced diet and regular physical activity. Dosage is tailored to individual needs, considering existing health status, blood sugar readings, and other medications. Consuming the tablets with meals minimizes gastrointestinal distress. Consistent daily dosing is crucial for maximum therapeutic benefit; discontinuation should only occur under medical supervision. Effective blood sugar control significantly reduces the likelihood of future complications. Maintaining the prescribed dietary and exercise regimen is paramount for successful diabetes management; lifestyle choices significantly impact disease control. Commonly reported side effects include nausea, vomiting, diarrhea, abdominal discomfort, headache, pharyngitis, fatigue, GERD, hyperhidrosis, and anorexia. Hypoglycemia is a potential adverse effect, particularly when used concurrently with insulin or sulfonylureas; proper recognition and management strategies are essential. This medication isn't suitable for all patients. Individuals with pre-existing renal, hepatic, or cardiac conditions, pancreatic disorders, or significant alcohol consumption should consult their physician prior to commencement. Similarly, pregnant or lactating women require medical consultation before use. Inform your doctor of all medications being taken to prevent potential drug interactions. Alcohol consumption should be minimized due to its hypoglycemic effects. Your physician will monitor renal function and blood glucose levels throughout the treatment course.

Primary Ingredients of Viglimepol Tablet

No information provided. Therefore, no rephrased text can be offered.

Uses of Viglimepol Tablet

Managing type 2 diabetes

Major Benefits of Viglimepol Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Viglimepol Tablet with a meal.

Common Side effects of Viglimepol Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Viglimepol Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Viglimepol Tablet with a meal.

How Viglimepol Tablet works:

The tablet Viglimepol contains a dual-action formulation for diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Viglimepol Tablet with alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Viglimepol Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Consult your doctor for advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Breastfeeding while taking Viglimepol Tablets is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Viglimepol tablets cautiously. A physician should be consulted to determine if a dosage modification is necessary.

LiverLiverUNSAFE

Patients with liver conditions should not take Viglimepol Tablets due to potential safety risks. Medical advice is recommended.

What if you forget to take Viglimepol Tablet :

Should you forget a Viglimepol Tablet dose, take it immediately. If, however, your next dose is nearly due, omit the missed dose and resume your usual schedule. Never take a double dose.

Facts to Know About Viglimepol Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Viglimepol Tablet

Viglimepol Tablets rarely cause hypoglycemia by themselves, but low blood sugar can result from inadequate caloric intake while using them. Hypoglycemia symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness. These symptoms are more likely if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Viglimepol Tablet. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Do not take other medications without your doctor's approval.
Viglimepol Tablets are contraindicated in patients with allergies to any ingredient or excipient. This medication should also not be used by individuals with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Viglimepol Tablet combines the anti-diabetic medications metformin (a biguanide) and vildagliptin. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated for individuals under 18.
Viglimepol Tablet use can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid. Also known as MALA (Metformin-associated lactic acidosis), this rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Viglimepol Tablet and seek immediate medical attention.
Prolonged Viglimepol Tablet use can lead to vitamin B12 deficiency by impairing its absorption in the stomach. This deficiency, if left untreated, may result in anemia and neurological complications.
Using Viglimepol Tablet as directed by your doctor is safe. However, even with correct dosage, you may experience side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, or low blood sugar (hypoglycemia, especially if also taking insulin or sulfonylurea). Report any persistent issues to your doctor.
Viglimepol Tablet
276
MRP 320
13% off